Cellular Constituents of Immune Escape within the Tumor MicroenvironmentKERKAR, Sid P; RESTIFO, Nicholas P.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 13, pp 3125-3130, issn 0008-5472, 6 p.Article

Local Delivery of Interleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in MiceCHINNASAMY, Dhanalakshmi; ZHIYA YU; KERKAR, Sid P et al.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1672-1683, issn 1078-0432, 12 p.Article

Determinants of Successful CD8⁺ T-Cell Adoptive Immunotherapy for Large Established Tumors in MiceKLEBANOFF, Christopher A; GATTINONI, Luca; ROSENBERG, Steven A et al.Clinical cancer research (Print). 2011, Vol 17, Num 16, pp 5343-5352, issn 1078-0432, 10 p.Article

Human effector CD8⁺ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyHINRICHS, Christian S; BORMAN, Zachary A; MURANSKI, Pawel et al.Blood. 2011, Vol 117, Num 3, pp 808-814, issn 0006-4971, 7 p.Article

Ocular and Systemic Autoimmunity after Successful Tumor-Infiltrating Lymphocyte Immunotherapy for Recurrent, Metastatic MelanomaYEH, Steven; KARNE, Need K; YANG, James C et al.Ophthalmology (Rochester, MN). 2009, Vol 116, Num 5, pp 981-989, issn 0161-6420, 9 p.Article

Genetic Engineering of Murine CD8⁺ and CD4⁺ T Cells for Preclinical Adoptive Immunotherapy StudiesKERKAR, Sid P; SANCHEZ-PEREZ, Luis; SCOTT, Christopher D et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 4, pp 343-352, issn 1524-9557, 10 p.Article

Tumor-Specific CD8⁺ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted HostsKERKAR, Sid P; MURANSKI, Pawel; MORGAN, Richard A et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 17, pp 6725-6734, issn 0008-5472, 10 p.Article